NM_001379081.2:c.6428A>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001379081.2(FREM1):​c.6428A>C​(p.Gln2143Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.731 in 1,612,218 control chromosomes in the GnomAD database, including 431,661 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 42516 hom., cov: 31)
Exomes 𝑓: 0.73 ( 389145 hom. )

Consequence

FREM1
NM_001379081.2 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.576

Publications

47 publications found
Variant links:
Genes affected
FREM1 (HGNC:23399): (FRAS1 related extracellular matrix 1) This gene encodes a basement membrane protein that may play a role in craniofacial and renal development. Mutations in this gene have been associated with bifid nose with or without anorectal and renal anomalies. Alternatively spliced transcript variants encoding different isoforms have been described. PubMed ID 19940113 describes one such variant that initiates transcription within a distinct, internal exon; the resulting shorter isoform (named Toll-like/interleukin-1 receptor regulator, TILRR) is suggested to be a co-receptor of the interleukin 1 receptor family and may regulate receptor function and Toll-like receptor/interleukin 1 receptor signal transduction, contributing to the control of inflammatory response activation. [provided by RefSeq, Apr 2011]
FREM1 Gene-Disease associations (from GenCC):
  • oculotrichoanal syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • BNAR syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • isolated trigonocephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • trigonocephaly 2
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.3810069E-6).
BP6
Variant 9-14737508-T-G is Benign according to our data. Variant chr9-14737508-T-G is described in ClinVar as Benign. ClinVar VariationId is 262545.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.779 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001379081.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FREM1
NM_001379081.2
MANE Select
c.6428A>Cp.Gln2143Pro
missense
Exon 37 of 37NP_001366010.1
FREM1
NM_144966.7
c.6428A>Cp.Gln2143Pro
missense
Exon 38 of 38NP_659403.4
FREM1
NM_001177704.3
c.2036A>Cp.Gln679Pro
missense
Exon 14 of 14NP_001171175.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FREM1
ENST00000380880.4
TSL:5 MANE Select
c.6428A>Cp.Gln2143Pro
missense
Exon 37 of 37ENSP00000370262.3
FREM1
ENST00000380894.5
TSL:1
c.2036A>Cp.Gln679Pro
missense
Exon 14 of 14ENSP00000370278.1
FREM1
ENST00000380875.7
TSL:1
n.*994A>C
non_coding_transcript_exon
Exon 31 of 31ENSP00000370257.3

Frequencies

GnomAD3 genomes
AF:
0.747
AC:
113483
AN:
151860
Hom.:
42495
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.786
Gnomad AMI
AF:
0.709
Gnomad AMR
AF:
0.751
Gnomad ASJ
AF:
0.827
Gnomad EAS
AF:
0.775
Gnomad SAS
AF:
0.652
Gnomad FIN
AF:
0.707
Gnomad MID
AF:
0.807
Gnomad NFE
AF:
0.730
Gnomad OTH
AF:
0.752
GnomAD2 exomes
AF:
0.735
AC:
181690
AN:
247034
AF XY:
0.731
show subpopulations
Gnomad AFR exome
AF:
0.790
Gnomad AMR exome
AF:
0.753
Gnomad ASJ exome
AF:
0.830
Gnomad EAS exome
AF:
0.776
Gnomad FIN exome
AF:
0.702
Gnomad NFE exome
AF:
0.738
Gnomad OTH exome
AF:
0.748
GnomAD4 exome
AF:
0.729
AC:
1064555
AN:
1460238
Hom.:
389145
Cov.:
43
AF XY:
0.727
AC XY:
528254
AN XY:
726350
show subpopulations
African (AFR)
AF:
0.787
AC:
26327
AN:
33462
American (AMR)
AF:
0.754
AC:
33611
AN:
44552
Ashkenazi Jewish (ASJ)
AF:
0.829
AC:
21645
AN:
26100
East Asian (EAS)
AF:
0.721
AC:
28582
AN:
39656
South Asian (SAS)
AF:
0.647
AC:
55717
AN:
86074
European-Finnish (FIN)
AF:
0.699
AC:
37277
AN:
53322
Middle Eastern (MID)
AF:
0.799
AC:
4605
AN:
5766
European-Non Finnish (NFE)
AF:
0.731
AC:
812275
AN:
1110988
Other (OTH)
AF:
0.738
AC:
44516
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
14728
29456
44184
58912
73640
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20082
40164
60246
80328
100410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.747
AC:
113560
AN:
151980
Hom.:
42516
Cov.:
31
AF XY:
0.745
AC XY:
55341
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.786
AC:
32560
AN:
41430
American (AMR)
AF:
0.751
AC:
11468
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.827
AC:
2869
AN:
3470
East Asian (EAS)
AF:
0.775
AC:
3994
AN:
5154
South Asian (SAS)
AF:
0.650
AC:
3123
AN:
4802
European-Finnish (FIN)
AF:
0.707
AC:
7460
AN:
10552
Middle Eastern (MID)
AF:
0.803
AC:
236
AN:
294
European-Non Finnish (NFE)
AF:
0.730
AC:
49618
AN:
67984
Other (OTH)
AF:
0.752
AC:
1587
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1465
2930
4394
5859
7324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.739
Hom.:
200619
Bravo
AF:
0.756
TwinsUK
AF:
0.720
AC:
2670
ALSPAC
AF:
0.741
AC:
2854
ESP6500AA
AF:
0.793
AC:
3022
ESP6500EA
AF:
0.734
AC:
6057
ExAC
AF:
0.732
AC:
88386
Asia WGS
AF:
0.686
AC:
2385
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Oculotrichoanal syndrome Benign:3
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
1.9
DANN
Benign
0.78
DEOGEN2
Benign
0.040
T
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.43
T
MetaRNN
Benign
0.0000014
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.83
L
PhyloP100
-0.58
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.090
N
REVEL
Benign
0.016
Sift
Benign
0.31
T
Sift4G
Benign
0.30
T
Polyphen
0.0010
B
Vest4
0.13
ClinPred
0.00098
T
GERP RS
-0.73
Varity_R
0.15
gMVP
0.84
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10961689; hg19: chr9-14737506; COSMIC: COSV66519900; API